Upstream Bio (UPB) Payables (2023 - 2026)

Upstream Bio has reported Payables for 4 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 63.76% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 63.76% YoY), and the FY2025 full-year result was $2.7 million, down 32.54% from the prior year.
• Payables for Q1 2026 stood at $1.7 million, down from $2.7 million in the prior quarter.
• The five-year high for Payables was $4.9 million in Q3 2024, with the low at $1.7 million in Q1 2026.
• Average Payables over 4 years is $3.3 million, with a median of $3.3 million recorded in 2025.
• Year-over-year, Payables jumped 103.07% in 2024 and tumbled 63.76% in 2026.
• Tracing UPB's Payables over 4 years: stood at $2.0 million in 2023, then surged by 103.07% to $4.0 million in 2024, then plunged by 32.54% to $2.7 million in 2025, then slumped by 37.27% to $1.7 million in 2026.
• The last three Payables figures came in at $1.7 million (Q1 2026), $2.7 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison